Explore 3 Stock Ideas & Industry Insights Download Free Report

8082-737-676
Shopping Cart 0
countryflagUK
Login

NetraMark Holdings Inc.

Healthcare CA AIAI

0.87CAD
0.00(0%)

Last update at 2026-06-03T19:48:00Z

Day Range

0.850.87
LowHigh

52 Week Range

0.681.12
LowHigh

Fundamentals

  • Previous Close 0.87
  • Market Cap84.85M
  • Volume77057
  • P/E Ratio-
  • Dividend Yield-%
  • Revenue TTM0.17M
  • Revenue Per Share TTM0.002
  • Gross Profit TTM 0.17M
  • Diluted EPS TTM-0.07

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Type yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Income before tax -5.22146M -3.33179M -14.16907M -13.69580M
Minority interest - - - -
Net income -5.22146M -3.33179M -14.16907M -13.44768M
Selling general administrative 5.70M 3.93M 5.45M 7.45M
Selling and marketing expenses - - - -
Gross profit - - - -
Reconciled depreciation - 0.00000M 0.61M 0.60M
Ebit - - - -
Ebitda - - - -
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -5.22146M -3.33179M -5.85867M -7.93203M
Other operating expenses - - - -
Interest expense - - - -
Tax provision - - 0.00000M -0.24812M
Interest income - - - -
Net interest income - - - -
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense - - - -
Total revenue 0.43M 0.46M 0.09M 0.11M
Total operating expenses 5.65M 3.79M 5.95M 8.05M
Cost of revenue - - - -
Total other income expense net 0.04M 0.14M -8.31040M -5.76377M
Discontinued operations - - - -
Net income from continuing ops -5.22146M -3.33179M -14.16907M -13.44768M
Net income applicable to common shares - - - -
Preferred stock and other adjustments - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Type yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Total assets 2.18M 0.21M 1.91M 9.20M
Intangible assets - - - 2.52M
Earning assets - - - -
Other current assets - - - -
Total liab 0.34M 0.41M 0.82M 1.09M
Total stockholder equity 1.83M -0.19856M 1.09M 8.11M
Deferred long term liab - - - -
Other current liab - - - -
Common stock - - - -
Capital stock 39.02M 30.50M 28.82M 24.25M
Retained earnings -41.54682M -36.32535M -32.99356M -18.82449M
Other liab - - - -
Good will - - 0.00000M 6.41M
Other assets - - - -
Cash 1.50M 0.06M 1.78M 0.01M
Cash and equivalents - - - -
Total current liabilities 0.34M 0.41M 0.82M 1.09M
Current deferred revenue - - - -
Net debt - - - -
Short term debt - - - -
Short long term debt - - - -
Short long term debt total - - - -
Other stockholder equity - - - -
Property plant equipment - - - -
Total current assets 2.18M 0.21M 1.91M 0.28M
Long term investments - - - -
Net tangible assets - - - -
Short term investments 0.53M 0.00515M 0.00500M 0.00500M
Net receivables 0.00000M 0.08M 0.00000M 0.00843M
Long term debt - - - -
Inventory - - - -
Accounts payable - - - -
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total 0.00000M 0.00000M 0.00000M 8.92M
Capital lease obligations - - - -
Long term debt total - - - -
Breakdown 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Type yearly yearly yearly yearly
Date 2025-09-30 2024-09-30 2023-09-30 2022-09-30
Investments -0.51375M 0.00000M 0.00000M 0.04M
Change to liabilities - - - -
Total cashflows from investing activities - - - -
Net borrowings - - - -
Total cash from financing activities 5.76M 0.57M 4.16M 0.69M
Change to operating activities - - - -
Net income -5.22146M -3.33179M -14.16907M -13.44768M
Change in cash 1.44M -1.71682M 1.77M -6.27602M
Begin period cash flow 0.06M 1.78M 0.01M 6.29M
End period cash flow 1.50M 0.06M 1.78M 0.01M
Total cash from operating activities -3.81344M -2.28982M -2.39041M -4.77815M
Issuance of capital stock - 0.00000M 3.97M 0.58M
Depreciation - 0.00000M 0.61M 0.60M
Other cashflows from investing activities - - - -
Dividends paid - - - -
Change to inventory - - - -
Change to account receivables 0.08M -0.08105M 0.00843M -0.00843M
Sale purchase of stock - - - -
Other cashflows from financing activities - - - -
Change to netincome - - - -
Capital expenditures 0.00000M 0.00000M 0.00000M 0.15M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital -0.06817M -0.43265M 0.23M 0.70M
Stock based compensation 0.82M 0.60M 1.43M 1.25M
Other non cash items 0.66M 0.88M 1.31M 0.61M
Free cash flow -3.81344M -2.28982M -2.39041M -4.93064M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
AIAI
NetraMark Holdings Inc.		 - -% 0.87 - - 513.40 71.64 504.87
VHI
Vitalhub Corp		 -0.46 6.17% 7.00 81.40 40.65 4.72 1.94 3.65 23.34
KSI
Kneat.com Inc		 -0.09 1.64% 5.40 - - 6.43 6.26 6.11 25.40

Reports Covered

Stock Research & News

View All

Profile

NetraMark Holdings Inc. provides AI-powered insights and software solutions to trial sponsors, clinical research organizations, and biotechnology companies worldwide. It operates NetraAI platform, an advanced machine learning system purpose-built for analyzing complex clinical trial data to identify meaningful patient subpopulations. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.

NetraMark Holdings Inc.

1655 Dupont Street, Toronto, ON, Canada, M6P 3T1

Key Executives

Name Title Year Born
Mr. George Achilleos President, CEO & Director NA
Dr. Joseph Geraci Ph.D. Founder, Chief Scientific & Technical Officer and Director NA
Mr. Swapan Kakumanu ACA, ACWA, CGA CFO & Corporate Secretary 1970
Mr. Josh Spiegel President of NetraMark Corp NA
Ms. Jaime Hackett Vice President of Marketing NA
Dr. Luca Pani M.D. Chief Innovation & Regulatory Officer and Chief Medical Advisor NA
Dr. Kaveh Kavoosi Head of Progressive Medicine NA
Dr. Larry Alphs Chief Medical Officer & Member of Advisory Board NA
Dr. Angelico Carta M.D. Chief Strategy Officer NA
Dr. Jan Sedway Ph.D. Senior Vice President of Clinical Science NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

We use cookies to help us improve, promote, and protect our services. By continuing to use this site, we assume you consent to our Cookies Policy. For more information, read our Privacy Policy and Terms and Conditions